Holen Sie sich die Stockscreener-App
86.18
1.35%
-1.18
Vorhandelsmarkt:
86.17
-0.01
-0.01%
Schlusskurs vom Vortag:
$87.36
Offen:
$87.66
24-Stunden-Volumen:
82,436
Relative Volume:
0.82
Marktkapitalisierung:
$575.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.12M
KGV:
-37.47
EPS:
-2.3
Netto-Cashflow:
$-6.82M
1W Leistung:
-5.88%
1M Leistung:
+7.83%
6M Leistung:
+165.50%
1J Leistung:
+316.33%
1-Tages-Spanne:
$84.00
$91.79
1-Wochen-Bereich:
$83.86
$100.50
52-Wochen-Spanne:
$19.87
$105.00
Monopar Therapeutics Inc Stock (MNPR) Company Profile
Firmenname
Monopar Therapeutics Inc
Sektor
Branche
Telefon
(847) 388-0349
Adresse
1000 SKOKIE BLVD SUITE 350, WILMETTE
Vergleichen Sie MNPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
86.18 | 583.79M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-14 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-11-10 | Eingeleitet | Leerink Partners | Outperform |
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-09-09 | Eingeleitet | BTIG Research | Buy |
| 2025-09-03 | Eingeleitet | Oppenheimer | Outperform |
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-08-26 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-19 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-10 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2021-01-28 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Monopar Therapeutics Inc Aktie (MNPR) Neueste Nachrichten
Is Monopar Therapeutics Inc. stock a safe investment in uncertain markets2025 Support & Resistance & Entry Point Strategy Guides - moha.gov.vn
Monopar Therapeutics Inc Stock Analysis and ForecastContrarian Investment Ideas & Free Rapid Portfolio Appreciation - earlytimes.in
What dividend safety score for Monopar Therapeutics Inc. stockNew Guidance & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Is Monopar Therapeutics Inc. stock a safe haven asset2025 Fundamental Recap & Weekly Breakout Watchlists - BỘ NỘI VỤ
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments - ADVFN
Trading Systems Reacting to (MNPR) Volatility - news.stocktradersdaily.com
Monopar Therapeutics Inc. (MNPR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is There An Opportunity With Monopar Therapeutics Inc.'s (NASDAQ:MNPR) 46% Undervaluation? - simplywall.st
Is Monopar Therapeutics Inc. (NASDAQ:MNPR) Trading At A 46% Discount? - Yahoo Finance
Monopar Therapeutics Shares Surge in Volatile Friday Session - Ad-hoc-news.de
Is Monopar Therapeutics Inc. stock a top momentum playTrade Signal Summary & Safe Entry Trade Signal Reports - newser.com
How geopolitical tensions affect Monopar Therapeutics Inc. stock2025 Institutional Moves & Growth Focused Investment Plans - newser.com
Will Monopar Therapeutics Inc. stock outperform Dow Jones indexMarket Volume Report & High Win Rate Trade Tips - newser.com
Why Monopar Therapeutics Inc. (1IY0) stock could be top winnerJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Why millennials buy Monopar Therapeutics Inc. (1IY0) stock2025 Support & Resistance & Free Fast Gain Swing Trade Alerts - newser.com
How Monopar Therapeutics Inc. (1IY0) stock expands through international marketsJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
Can Monopar Therapeutics Inc. stock sustain market leadershipJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
How Monopar Therapeutics Inc. (1IY0) stock correlates with oil markets2025 Investor Takeaways & Weekly Momentum Picks - newser.com
What moving averages say about Monopar Therapeutics Inc.Weekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
How Monopar Therapeutics Inc. (1IY0) stock reacts to monetary easingQuarterly Portfolio Summary & Growth Oriented Trading Recommendations - newser.com
Monopar Therapeutics Inc. stock prediction for this week2025 Pullback Review & Risk Controlled Daily Plans - newser.com
Is Monopar Therapeutics Inc. (1IY0) stock attractive for growth fundsJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
Will Monopar Therapeutics Inc. (1IY0) stock sustain dividend payouts2025 Trading Volume Trends & Weekly Top Gainers Alerts - newser.com
Is Monopar Therapeutics Inc. stock entering bullish territoryJuly 2025 Weekly Recap & Low Risk High Reward Trade Ideas - newser.com
Is Monopar Therapeutics Inc. stock attractive for retirement portfoliosJuly 2025 Outlook & Long-Term Safe Investment Ideas - newser.com
Optimistic Buy Rating for Monopar Therapeutics Inc: Promising ALXN1840 Data and Strong Financial Position - TipRanks
Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Monopar Therapeutics Inc-Aktie (MNPR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tsuchimoto Kim R | Director |
Jul 14 '25 |
Sale |
40.00 |
8,904 |
356,171 |
11,486 |
| STARR CHRISTOPHER M | Director |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
5,173 |
| Robinson Chandler | Chief Executive Officer |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
73,472 |
0.45%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):